ZA200204492B - Heterocyclic derivatives. - Google Patents
Heterocyclic derivatives.Info
- Publication number
- ZA200204492B ZA200204492B ZA200204492A ZA200204492A ZA200204492B ZA 200204492 B ZA200204492 B ZA 200204492B ZA 200204492 A ZA200204492 A ZA 200204492A ZA 200204492 A ZA200204492 A ZA 200204492A ZA 200204492 B ZA200204492 B ZA 200204492B
- Authority
- ZA
- South Africa
- Prior art keywords
- heterocyclic derivatives
- heterocyclic
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9929037.1A GB9929037D0 (en) | 1999-12-08 | 1999-12-08 | Heterocyclic derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200204492B true ZA200204492B (en) | 2004-06-30 |
Family
ID=10865952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200204492A ZA200204492B (en) | 1999-12-08 | 2002-06-05 | Heterocyclic derivatives. |
Country Status (30)
Country | Link |
---|---|
US (2) | US6713491B2 (ja) |
EP (1) | EP1237886B1 (ja) |
JP (1) | JP4311901B2 (ja) |
KR (1) | KR100788579B1 (ja) |
CN (1) | CN1325488C (ja) |
AR (1) | AR030923A1 (ja) |
AT (1) | ATE323691T1 (ja) |
AU (1) | AU769232B2 (ja) |
BR (1) | BR0016235A (ja) |
CA (1) | CA2393303C (ja) |
CO (1) | CO5251474A1 (ja) |
CY (1) | CY1106105T1 (ja) |
CZ (1) | CZ301052B6 (ja) |
DE (1) | DE60027461T2 (ja) |
DK (1) | DK1237886T3 (ja) |
ES (1) | ES2257343T3 (ja) |
GB (1) | GB9929037D0 (ja) |
HK (1) | HK1047436B (ja) |
HU (1) | HUP0203650A3 (ja) |
IL (2) | IL150010A0 (ja) |
MX (1) | MXPA02005802A (ja) |
MY (1) | MY129892A (ja) |
NO (1) | NO323263B1 (ja) |
PL (1) | PL356713A1 (ja) |
PT (1) | PT1237886E (ja) |
TN (1) | TNSN00240A1 (ja) |
TR (1) | TR200201503T2 (ja) |
TW (1) | TW524804B (ja) |
WO (1) | WO2001042238A1 (ja) |
ZA (1) | ZA200204492B (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004096785A1 (ja) * | 2003-04-25 | 2004-11-11 | Nippon Chemiphar Co., Ltd. | (2s,3s)-3-[[(1s)-1-イソブトキシメチル-3-メチルブチル]カルバモイル]オキシラン-2-カルボン酸の塩 |
GB0327912D0 (en) * | 2003-12-02 | 2004-01-07 | Glaxo Group Ltd | Medicament |
US7576216B2 (en) | 2004-07-30 | 2009-08-18 | Abbott Laboratories | Preparation of pyridonecarboxylic acid antibacterials |
LT3056492T (lt) | 2004-10-08 | 2022-01-25 | Abbvie Inc. | Meglumino druska ir atitinkamos vaisto (delafloksacino) kristalinės formos |
DK1868581T3 (da) * | 2005-04-11 | 2012-07-09 | Abbott Lab | Farmaceutiske sammensætninger med forbedrede opløsningsprofiler til dårligt opløselige lægemidler |
EP3091009B1 (en) * | 2011-10-25 | 2018-08-29 | Janssen Pharmaceutica NV | Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5231102A (en) | 1989-03-08 | 1993-07-27 | Merck Sharp & Dohme, Ltd. | Tetrahydroquinoline derivatives useful for neurodegenerative disorders |
US5529999A (en) | 1994-03-04 | 1996-06-25 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
US6413959B1 (en) * | 1995-04-14 | 2002-07-02 | Boehringer Ingelheim Kg | Method of treating depression with arylglycinamide derivatives |
PL186781B1 (pl) | 1995-09-29 | 2004-02-27 | Glaxo Wellcome Spa | Nowy związek, pochodna tetrahydrochinoliny, sposób wytwarzania pochodnej tetrahydrochinoliny, środek farmaceutyczny i zastosowanie |
GB9617305D0 (en) | 1996-08-17 | 1996-09-25 | Glaxo Wellcome Spa | Heterocyclic compounds |
MY125037A (en) * | 1998-06-10 | 2006-07-31 | Glaxo Wellcome Spa | 1,2,3,4 tetrahydroquinoline derivatives |
-
1999
- 1999-12-08 GB GBGB9929037.1A patent/GB9929037D0/en not_active Ceased
-
2000
- 2000-07-12 US US10/148,434 patent/US6713491B2/en not_active Expired - Fee Related
- 2000-12-06 MY MYPI20005714A patent/MY129892A/en unknown
- 2000-12-07 JP JP2001543537A patent/JP4311901B2/ja not_active Expired - Fee Related
- 2000-12-07 DK DK00983240T patent/DK1237886T3/da active
- 2000-12-07 IL IL15001000A patent/IL150010A0/xx unknown
- 2000-12-07 BR BR0016235-3A patent/BR0016235A/pt not_active Application Discontinuation
- 2000-12-07 WO PCT/EP2000/012335 patent/WO2001042238A1/en active IP Right Grant
- 2000-12-07 PL PL00356713A patent/PL356713A1/xx not_active Application Discontinuation
- 2000-12-07 KR KR1020027007260A patent/KR100788579B1/ko not_active IP Right Cessation
- 2000-12-07 AU AU20060/01A patent/AU769232B2/en not_active Ceased
- 2000-12-07 AR ARP000106511A patent/AR030923A1/es unknown
- 2000-12-07 EP EP00983240A patent/EP1237886B1/en not_active Expired - Lifetime
- 2000-12-07 ES ES00983240T patent/ES2257343T3/es not_active Expired - Lifetime
- 2000-12-07 HU HU0203650A patent/HUP0203650A3/hu unknown
- 2000-12-07 CN CNB00816875XA patent/CN1325488C/zh not_active Expired - Fee Related
- 2000-12-07 TR TR2002/01503T patent/TR200201503T2/xx unknown
- 2000-12-07 CZ CZ20021981A patent/CZ301052B6/cs not_active IP Right Cessation
- 2000-12-07 PT PT00983240T patent/PT1237886E/pt unknown
- 2000-12-07 CO CO00093651A patent/CO5251474A1/es not_active Application Discontinuation
- 2000-12-07 TW TW089126096A patent/TW524804B/zh not_active IP Right Cessation
- 2000-12-07 CA CA002393303A patent/CA2393303C/en not_active Expired - Fee Related
- 2000-12-07 DE DE60027461T patent/DE60027461T2/de not_active Expired - Lifetime
- 2000-12-07 MX MXPA02005802A patent/MXPA02005802A/es active IP Right Grant
- 2000-12-07 AT AT00983240T patent/ATE323691T1/de active
- 2000-12-08 TN TNTNSN00240A patent/TNSN00240A1/en unknown
-
2002
- 2002-06-03 IL IL150010A patent/IL150010A/en not_active IP Right Cessation
- 2002-06-05 ZA ZA200204492A patent/ZA200204492B/xx unknown
- 2002-06-06 NO NO20022682A patent/NO323263B1/no not_active IP Right Cessation
- 2002-12-14 HK HK02109085.5A patent/HK1047436B/zh not_active IP Right Cessation
-
2004
- 2004-02-10 US US10/775,709 patent/US6943176B2/en not_active Expired - Fee Related
-
2006
- 2006-06-26 CY CY20061100855T patent/CY1106105T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200000894B (en) | 4-Phenyl-pyridine derivatives. | |
ZA200201055B (en) | Amino-triazolopyridine derivatives. | |
HK1051695A1 (en) | N6 heterocyclic 8-modified andenosine derivatives. | |
HK1041885A1 (en) | Amide derivatives. | |
GC0000183A (en) | 3-Phenyl-pyridine derivatives | |
ZA200203003B (en) | N-substituted carbamoyloxyalkyl-azolium derivatives. | |
ZA200109595B (en) | 13-methyl-erythromycin derivatives. | |
HK1046411A1 (en) | 5-Phenyl-pyrimidine derivatives. | |
IL148058A0 (en) | Substituted 2-dialkylaminoalkylbiphenyl derivatives | |
HK1044940A1 (zh) | 異噁唑咪唑羧酰胺衍生物 | |
GC0000191A (en) | 4-Phenyl-pyrimidine derivatives | |
MXPA01012041A (es) | Derivados de indol. | |
MXPA00011504A (es) | Derivados heterociclicos sustituidos. | |
HK1049161A1 (en) | Indole derivatives. | |
ZA200201276B (en) | 3-Amino-2-phenyl-propane derivatives. | |
GB9925880D0 (en) | B-Carboline derivatives | |
HK1048638A1 (zh) | Cyclopenteneone衍生物 | |
GC0000256A (en) | Ethanesulfonyl-piperidine derivatives | |
ZA200204492B (en) | Heterocyclic derivatives. | |
AP2001002327A0 (en) | 1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives | |
MXPA01011285A (es) | Derivados de tio-oxindol. | |
GB9929038D0 (en) | Heterocyclic derivatives | |
GB9903337D0 (en) | Heterocyclic derivatives | |
ZA993232B (en) | Arylthiazolidinedione derivatives. | |
ZA200107632B (en) | Thio-oxindole derivatives. |